| Literature DB >> 24286957 |
Sarah D Corathers1, Shawn Peavie, Marzieh Salehi.
Abstract
Current strategies for the treatment of type 2 diabetes mellitus promote individualized plans to achieve target glucose levels on a patient-by-patient basis while minimizing treatment related risks. Maintaining glycemic control over time is a significant challenge because of the progressive nature of diabetes as a result of declining β-cell function. This article identifies complications of non-insulin treatments for diabetes. The major classes of medications are reviewed with special focus on target population, mechanism of action, effect on weight, cardiovascular outcomes and additional class-specific side effects including effects on bone. Effects on β-cell function are also highlighted.Entities:
Keywords: Cardiovascular outcomes; Diabetes; Treatment complications; β-cell function
Mesh:
Substances:
Year: 2013 PMID: 24286957 PMCID: PMC6533625 DOI: 10.1016/j.ecl.2013.06.005
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN: 0889-8529 Impact factor: 4.741